Argonaut Technologies' Stockholders Approve Sale of Assets to Biotage
Argonaut Technologies announced that its stockholders have approved the sale of the assets of its chemistry consumables business and certain assets of its process chemistry business, which constitute substantially all of its assets except for its cash, to Biotage AB of Uppsala, Sweden. Argonaut and Biotage expect to close the transaction on June 3, 2005.
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Carnegie Mellon chemists characterize 3-D macroporous hydrogels - Methods will allow researchers to develop new 'smart' materials
Chemists allow boron atoms to migrate - Researchers present carbon-carbon couplings in which the semi-metal boron is retained
Public consultation launched on SEAC's draft opinion on restricting four phthalates
Sales growth fuels Freeman Technology expansion into new HQ

Simulating complex catalysts key to making cheap, powerful fuel cells
GEA sees strong order intake in fourth quarter
Category:Tantalum_compounds
